Treatment of acute uncomplicated cystitis in women with antibiotic allergy or intolerance


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim: A comparative evaluation of the efficacy and safety of Canephron N and Cystone as monotherapy in women with acute uncomplicated cystitis and antibiotic allergy or intolerance was performed. Materials and methods. A prospective, randomized, controlled study of drug Canephron N as monotherapy for acute uncomplicated cystitis in 51 women with a history of antibiotic allergy or intolerance was carried out in 3 urological centers in Perm from 2016 to 2019. In the main group, patients received Canephron N for 30 days, while in comparison group, Cystone was prescribed. The Acute Cystitis Symptom Score (ACSS), microscopic study of urine sediment, urine culture and other methods were used. Results were evaluated 3, 6, 30 days and 1 year after the start of treatment. Results. In the main group, monotherapy with Canephron N for 30 days resulted in a decrease in the total ACSS score from the baseline 12.9 to 0.3 points, while in Cyston group, changes of ACSS score were less pronounced, from baseline 12.8 to 1.4 points (p<0.01). Clinical cure rate in the main and comparison group was 88.5% and 68%, respectively. In another 3.8% and 1% of patients in the main and comparison group, an improvement was seen. The number of patients with leukocyturia in the Canephron N group decreased to 11.5% compared to 28% in Cyston group (p>0.05). Bacteriuria rate in the main group was 7.7%, which was less than in the comparison group (20%, p> 0.05). Number of sick days in the main group was 4.9+0.4, compared to 7.4+0.6 days in Cyston group. In the Canephron N group, 1-year recurrence rate was only 7.7%, while in the Cyston group the recurrence was seen in 16% of patients. Conclusion. According to the results, Canephron N is an effective and safe drug as monotherapy for acute uncomplicated cystitis, and can be considered as drug of choice for the treatment of women with antibiotic allergy or intolerance.

Full Text

Restricted Access

About the authors

M. I Davidov

FGBOU VO “Academician Ye.A. Vagner Perm State Medical University”

Email: lenarata@yandex.ru

D. A Voitko

N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology

N. E Bunova

FGBOU VO “Academician Ye.A. Vagner Perm State Medical University”

References

  1. Grigoryan L., Zoorob R., Wang H., Trautner B. W. Low Concordance With Guidelines for Treatment of Acute Cystitis in Primary Care. Open Forum Infect Dis. 2015; 2(4): 159. doi: 10.1093/ofid/ofv 159.
  2. Wagenlehner F.M., Weidner W., Naber K.G. An update on uncomplicated urinary tract infections in women. Curr Opin Urol. 2009;19: 368-374.
  3. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010;7: 653-660.
  4. Зайцев А.В., Касян Г.Р., Спивак Л.Г. Цистит. Урология. 2017;1(Прил. 1):34-44
  5. Аляев Ю.Г., Глыбочко П.В., Пушкарь Д.Ю. Урология. Российские клинические рекомендации. М.: ГЭОТАР-Медиа; 2018. 480 с
  6. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М., 2015: 23-29
  7. EAU Guidelines. Edn. Presented at the EAU Annual Congress Copenhagen 2018. ISBN 978-94-92671-01-1. www.http://uroweb.org/guideline/ urological-infections/
  8. Рациональная фармакотерапия в урологии. Под ред. Н.А. Лопаткина, Т.С. Перепановой. М.: Литтерра; 2012. 800 с
  9. Kunin C.M. Urinary tract infections: detection, Prevention and Management. 5 th ed. Baltimore: Williams and Wilkins; 1997. 340 p.
  10. Reese R.E., Betts R.F., Gumustop B. Handbook of antibiotics 3 ed. Philadelphia: Williams and Wilkins; 2000.415.
  11. Scholar E.M., Pratt W.B. The antimicrobial drugs. 2 ed. Oxford: University Press; 2000.
  12. Gagyor I., Bleidorn J., Kochen M.M., Schmiemann G., Wegscheider K., Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomized controlled trial. BMJ. 2015;351:h6544.
  13. Kronenberg A., Butikofer L., Odutayo A., Muhlemann K., da Costa B.R., Battaglia M., Meli D.N., Limacher A., Reichenbach S., Juni P. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ 2017;359:j4784.
  14. Аляев Ю.Г., Амосов А.В., Султанова Е.А. Канефрон Н. Обзор фармакологических и клинических данных. М.; 2015. 128 с
  15. Haloui M., Louedec J.B.,MichelJ.B., Lyoussi B. Experimental diuretic effects of Rosmarinus officinalis and Centauriumerythraea. J Ethnopharmacol. 2000;71:465-472.
  16. Kunstle G., Brenneis C., Haunschild J. Efficacy of Canephron N against bacterial adhesion inflammation and bladder hyperactivity. Eur Urol. Suppl 2013;12:е671.
  17. Kunstle G., Brenneis C., Pergola C., Werz O., Haunschild J. Antiinflammatory effects of Canephron N and effectiveness in a model of interstitial cystitis. Urologe 2013;52(Suppl. 1):e97.
  18. Alidjanov J.F., Abdufattaev U.A., Makhsudov S.A., Pilatz A., Akilov F.A., Naber K.G.,Wagenlehner F.M. New self-reporting guestionnaire to assess urinary tract infections and differential diagnosis: acute cystitis symptom score. Urol Int.2014;92(2):230-236. doi: 10.1159/000356177.
  19. Амдий Р.Э., Аль-Шукри С.Х., Кузьмин И.В., Сорокин М.В., Чаплицкий Е.А., Скворцов М.В., Алексеев А.С.,Окунчаев А.Ш., Турбин А.А., Тимаева Г.Р., Булаев Д.В., Москалева Ю.С. Опыт применения канефрона при лечении острого неосложненного цистита у женщин. Урологические ведомости. 2016;6(2):16-22
  20. Давидов М.И., Бунова Н.Е. Сравнительная оценка монотерапии препаратами Канефрон Ниципрофлоксацин острого неосложненного цистита у женщин. Урология. 2018 ;4:24-32. Doi: https://dx.doi.org/10.18565/ urology.2018.4.24.32
  21. Кульчавеня Е.В., Бреусов А.А., Брижатюк Е.В., Шевченко С.Ю. Острый цистит - всегда ли нужен антибиотик ?Урология. 2016;1:25-28
  22. Вешкина А.А., Журавлев О.В., Семаков Д.В., Кузуб И.И., Баженов И.В. Возможности фитотерапии в лечении неосложненных инфекций мочевыводящих путей. Уральский медицинский журнал. 2017;2:130-132
  23. Wagenlehner F.M., Abramov-Sammariva D.,Holler M., Steindl H., Naber K.G. Non-antibiotic herbal therapy (BNO 1045) versus antibiotic therapy (Fosfomycin trometamol) for the treatment of acute lower uncomplicated urinary tract infections in women: A double-blind, parallel-Group, randomized, multicentre, non-inferiority phase III trial. Urologia Internationalis. 2018;101:327-336. doi: 10.1159/000493368

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies